NCT04923126 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04923126
Title	SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	St. Jude Children's Research Hospital
Indications	malignant astrocytoma oligodendroglioma pilomyxoid astrocytoma central neurocytoma low grade glioma gangliocytoma diffuse astrocytoma mixed oligodendroglioma-astrocytoma dysembryoplastic neuroepithelial tumor ganglioglioma pilocytic astrocytoma pleomorphic xanthoastrocytoma
Therapies	Mirdametinib
Age Groups:	child \| adult
Covered Countries	USA

NCT04923126
Clinical Trial Detail